News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Anna P. Shapiro-Krew, MD

Dr Shapiro-Krew is the director of Epilepsy Psychiatry at Cleveland Clinic's Neurological Institute.

Articles by Anna P. Shapiro-Krew, MD

antiepileptics

What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics

ByAnna P. Shapiro-Krew, MD

January 12th 2026

Explore the unique mood-stabilizing properties of antiepileptics like lamotrigine, valproic acid, and carbamazepine in bipolar disorder treatment.

It’s Not Normal: A Discussion of Psychosis in Epilepsy

ByAnna P. Shapiro-Krew, MD

January 7th 2026

Explore the complex relationship between epilepsy and psychosis, including forced normalization and treatment strategies for affected patients.

Latest Updated Articles

Trending on Psychiatric Times

A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap

Treating Inflammation to Relieve Depression, Anhedonia

Retention in Care: The Good, the Bad, and the Ugly

The Psychopharmacology of Personality Disorders

One Year After the President’s Inauguration